NDC11 69097031602
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 69097-0316-02 | 69097-0316 |
| 69097-0316-2 | 69097-0316 |
| 69097-316-02 | 69097-316 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| EXEMESTANE | EXEMESTANE | Cipla USA Inc. | abde1ccd-0ec9-40d4-b205-fbc00f5878b9 | 2025-02-09 | Warnings, Adverse reactions | 69097-316-02 69097-316 69097031602 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.